CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 175 filers reported holding CLOVIS ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3 | -100.0% | 60,000 | +50.0% | 0.00% | -88.9% |
| Q3 2022 | $48,000 | -33.3% | 40,000 | 0.0% | 0.01% | -30.8% |
| Q2 2022 | $72,000 | +80.0% | 40,000 | +100.0% | 0.01% | +116.7% |
| Q1 2022 | $40,000 | -25.9% | 20,000 | 0.0% | 0.01% | -25.0% |
| Q4 2021 | $54,000 | -39.3% | 20,000 | 0.0% | 0.01% | -42.9% |
| Q3 2021 | $89,000 | -23.3% | 20,000 | 0.0% | 0.01% | -22.2% |
| Q2 2021 | $116,000 | -17.1% | 20,000 | 0.0% | 0.02% | -21.7% |
| Q1 2021 | $140,000 | +45.8% | 20,000 | 0.0% | 0.02% | +35.3% |
| Q4 2020 | $96,000 | +65.5% | 20,000 | +100.0% | 0.02% | +30.8% |
| Q3 2020 | $58,000 | -14.7% | 10,000 | 0.0% | 0.01% | -13.3% |
| Q2 2020 | $68,000 | -46.5% | 10,000 | -50.0% | 0.02% | -57.1% |
| Q1 2020 | $127,000 | +22.1% | 20,000 | +100.0% | 0.04% | +66.7% |
| Q4 2019 | $104,000 | +166.7% | 10,000 | 0.0% | 0.02% | +162.5% |
| Q3 2019 | $39,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |